Callitas Health Inc

OTC Pink | Jul 3, 2020, 9:40 AM EDT

MPHMF:US $ 0.10
0.00 (0.00%)
Day Low: N/A
Day High: N/A
InvestmentPitch Media Video Discusses Callitas Health's Consulting Agreement with BFS Innovations and Pure Leaf Group for Cannabis Delivery Technology - Video Available on

Vancouver, British Columbia--(Newsfile Corp. - August 24, 2018) - Callitas Health Inc. (CSE: LILY) (OTCQB: MPHMF) (FSE: T3F3) has signed a consulting agreement with BFS Innovations and Pure Leaf Group to globally launch the company's patent-pending cannabis delivery technology and proprietary business model.

Cannot view this video? Visit: has produced a "video" which discusses this news. If this link is not enabled, please visit and enter "Callitas" in the search box.

Scott Allen, President of Pure Leaf Group, stated: "BFS Innovations and Pure Leaf Group are excited to be partnering with Callitas, as it brings its proprietary actives delivery system and tightly controllable dosing technology to this rapidly growing market. CannaStrip's proprietary actives delivery system and tightly controllable sublingual dosing technology are key differentiators for companies who are seeking a competitive edge in the rapidly emerging cannabis marketplace."

Pure Leaf Group, founded to meet the needs of the rapidly evolving and highly-regulated cannabis industry, provides complete consulting and product development solutions for companies entering or currently operating in the growing cannabis and CBD market.

James Thompson, President and CEO of Callitas, added: "This partnership allows Callitas to expand its reach and engage more groups locally and internationally. Our CannaStrip technology is amazing, and as we continue to expand our IP portfolio of cannabis tech, Callitas will be able to leverage BFS Innovations and Pure Leaf Group's experience to grow sales."

Formed in early 2015, Callitas Health is an integrated clinical-stage pharmaceutical development and OTC consumer goods marketing company, focused on developing innovative technologies for weight management, female sexual health and wellness, cannabis delivery technologies and other proprietary drugs. The company is focused on bringing pharmaceutical best practices to the cannabis space through controlled dosing, improved bioavailability and advanced manufacturing techniques.

Joshua Maurice, Director of Sales and Marketing for Callitas, commented: "Our proprietary business model for manufacturing and distribution is novel and efficient. By partnering with BFS Innovations and Pure Leaf Group, we are accelerating our speed-to-market on a state-by-state level, which is very exciting."

For more information, please visit the company's website,, contact James Thompson, President and CEO, at 859-868-3131 or by email

Investor relations is handled by Kevin McGrath, Managing Director at TraDigitalIR, who can be reached at 646-418-7002, or by email at

About InvestmentPitch Media

Investmentpitch Media leverages the power of video, which together with its extensive distribution, positions a company's story ahead of the 1,000's of companies seeking awareness and funding from the financial community. The company specializes in producing short videos based on significant news releases, research reports and other content of interest to investors.

InvestmentPitch Media
Barry Morgan, CFO

Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. View delay times for all exchanges. Market Data powered by QuoteMedia. See the QuoteMedia Terms of Use.